Press Release Summary:
Equipped with Dynamic Compensation(TM) algorithm, EQUANOX(TM) Advance 8004CB Series automatically accounts for pediatric brain-tissue-development variation when measuring oxygen saturation levels. Sensors are used with EQUANOX(TM) Advance Model 7600 Oximetry System on patients weighing less than 40 kg. Utilizing dual-light emitting and detecting architecture, sensors enable up to 4 channels to be displayed on one screen. Data output is available via BluetoothÂ® wireless technology or RS232 connection.
Original Press Release:
Nonin Medical, Inc. Announces U.S. Market Release of EQUANOX(TM) Advance Model 8004CB Series Sensor for Neonatal, Pediatric Patients
First and only cerebral/somatic sensor to automatically account for pediatric brain-tissue-development variation when measuring oxygen saturation levels
MINNEAPOLIS, -- Nonin Medical, Inc. announced today the U.S. market release of its EQUANOX(TM) Advance Model 8004CB Series neonatal/pediatric sensor. The EQUANOX Advance 8004CB Series Sensor with Nonin's patent-pending Dynamic Compensation(TM) algorithm is the first and only cerebral/somatic sensor to automatically account for pediatric brain-tissue-development variation when measuring oxygen saturation levels. The sensors are designed for use with Nonin's EQUANOX(TM) Advance Model 7600 Oximetry System in cerebral or somatic positions on patients weighing less than 40 kg.
EQUANOX is a near infra-red spectroscopy (NIRS)-based monitoring device that noninvasively and continuously detects oxygen saturation status in brain and other tissue. The device allows clinicians to quickly react to reverse harmful tissue ischemia events before they become critical.
"Nonin Medical is pleased to announce this latest advancement in tissue oxygen saturation monitoring for neonatal and pediatric patients," said Kevin McGowan, Vice President-Global Sales for Nonin Medical. "Until now, pediatric cerebral/somatic oximetry sensors have essentially been trimmed versions of adult sensors. Nonin's 8004CB Sensor is designed specifically for pediatric patients. The sensor features adhesive and non-adhesive versions for delicate skin, a small footprint for space-saving placement, short light-path spacing for pediatric-appropriate tissue-depth readings, and Nonin's Dynamic Compensation(TM) algorithm for calculating accurate, patient-specific values. And because the 8004CB provides a single-sensor solution for all patients less than 40 kg, it simplifies protocols and inventory requirements, saving time and money."
"Nonin's EQUANOX(TM) Advance 8004CB sensor represents a major step forward in pediatric patient monitoring because it provides absolute, real-time accuracy of cerebral oxygenation status without requiring the physician to input patient demographics or stock and choose from multiple sensors," said Dr. Dean Kurth, Anesthesiologist-in-Chief for Cincinnati Children's Hospital Medical Center.
"The problem is, light attenuation of pediatric brain tissue changes with age and varies from patient to patient, which can impact traditional cerebral oximetry systems," Kurth said. "To compensate for this, some pediatric oximetry systems require physicians to choose from different sensor sizes or enter the patient's age or weight to obtain accurate rSO2 measurements. Nonin's new 8004CB Sensor, with its Dynamic Compensation algorithm, is the first sensor to automatically adjust for pediatric brain myelination changes. So now physicians have a single-sensor solution that provides oxygen saturation readings based on the child's true physiology."
The EQUANOX Advance 8004CB and 8004CB-NA (non-adhesive) Neonatal/Pediatric Sensors, along with the Model 7600 Oximetry System, provide additional advantages including:
-- Cerebral and Somatic Monitoring - Up to four channels displayed on one screen for monitoring oxygen saturation in the brain and somatic sites on the body, including kidney and liver sites
-- Patented Dual-Light Emitters and Detectors with Four Wavelength Accuracy
- The first and only device that utilizes a dual-light emitting and detecting sensor architecture, which has been shown to more effectively target the cerebral cortex, eliminating surface artifacts that interfere with measurement accuracy(1)
-- Absolute Accuracy - Assures accurate measure of tissue saturation at a point in time, not just relative or trending accuracy of changes
-- Consistency and Reliability - Rapid, reliable response to change without signal instability and interruptions from ambient electrical and light interferences
-- Portability and Connectivity - Lightweight, durable monitor with long battery life and pole-mounting capability for continually monitoring patients during intra-hospital transport. Data output available via Bluetooth® wireless technology or RS232 connection. Interfaces with Philips® VueLink (through Philips IntelliVue® Monitor), Philips CompuRecord Anesthesia Information System, Spectrum Medical VIPER Independent Data Management System and Sorin Perfusion Data Management System.
Contact Nonin Medical at 1.800.356.8874 or visit www.noninequanox.com for more information or to schedule an on-site evaluation.
About Nonin Medical, leaders in noninvasive medical monitoring
Nonin Medical, Inc. invented finger pulse oximetry and designs and manufactures innovative, noninvasive medical monitoring solutions to meet customers' technology needs today and tomorrow. Headquartered in Minneapolis, Minn. with an additional service center in Hudiksvall, Sweden, Nonin Medical sells its pulse and regional oximeters, capnographs, sensors and software to health professionals and consumers in more than 125 countries. The company also has more than 100 OEM partners worldwide. For more information, visit www.nonin.com.
(1) Davie SN, Grocott HP. Impact of Extracranial Contamination on Regional Cerebral Oxygen Saturation: A Comparison of Three Cerebral Oximetry Technologies. Anesthesiology. 2012; 116(4):1-7.
CONTACT: Melanie Stanek, Director, Corporate Communications, Nonin Medical, Inc., +1-763-577-5514, firstname.lastname@example.org
Web Site: www.nonin.com